Abstract
Kidney organoids, as three-dimensional in vitro models that simulate human kidney structure and function, demonstrate significant potential in disease modeling, drug screening, and regenerative medicine. However, the lack of a well-developed vascular network within these organoids restricts their morphological and functional maturation, presenting a critical bottleneck in current research. This review summarizes the latest advancements in the vascularization of kidney organoids, focusing on the molecular mechanisms of angiogenesis, such as the regulation of HIF-1α, the role of biomaterials and microenvironments like decellularized kidney matrix hydrogels, and bioengineering technologies including microfluidic chips and genetically engineered endothelial cells. Furthermore, strategies for promoting vascularization through in vivo transplantation are discussed. The review also explores the prospects and challenges of vascularized kidney organoids in constructing disease models, studying immune rejection, and clinical transplantation applications. By integrating cutting-edge biotechnologies and engineering approaches, achieving efficient vascularization of kidney organoids will provide a robust platform for investigating the mechanisms of kidney diseases and facilitating personalized therapies.
Introduction: The "Bloodless" Bottleneck
Kidney organoids derived from induced pluripotent stem cells (iPSCs) represent a breakthrough in regenerative medicine, offering sophisticated 3D models of human renal tissue. However, these organoids currently face a significant developmental hurdle: they remain "stuck" in an embryonic state. The primary cause is the absence of a functional vascular network.
In native physiology, blood vessels do more than transport oxygen and nutrients; they provide essential mechanical cues and biochemical signals necessary for nephron maturation. Without this "plumbing," organoids suffer from internal necrosis as they increase in size, fail to develop mature filtration barriers—such as the glomerular basement membrane—and cannot perform the kidney's fundamental role in waste filtration.
Technological Strategies for Vascularization
Current research utilizes a multi-disciplinary "vascularization toolkit" categorized into four primary technological pillars.
1. Biomimetic Scaffolds
Researchers utilize decellularized kidney matrix (dECM) hydrogels to provide a naturalistic environment. By removing cellular components from a native kidney, a scaffold is created that retains the organ's complex architecture and biochemical "instructions," which guide the growth of new vessels.
2. Bioengineering and Microfluidics
- 3D Bioprinting: This involves the precise deposition of endothelial cells and renal progenitors in specific geometries to encourage the formation of interconnected networks.
- Organ-on-a-Chip: Microfluidic devices allow researchers to subject organoids to fluid shear stress. This mimics the mechanical "push" of blood flow, which is a critical requirement for endothelial cell maturation and the formation of stable barriers.
3. Genetic Engineering
By manipulating "master switches" like the transcription factor ETV2 or the hypoxia-inducible factor HIF-1α, researchers can direct cell fate more efficiently. For instance, overexpressing ETV2 can force iPSCs to differentiate into endothelial cells with over 90% efficiency, bypassing complex growth factor cocktails.
4. In Vivo Transplantation
This strategy leverages host biology by transplanting organoids into the renal subcapsular space of immunodeficient mice or onto the chorioallantoic membrane (CAM) of chicken embryos. These models allow the organoid to recruit existing blood vessels from the host, creating a chimeric circulatory system.
Key Insights and Mechanisms
A critical realization in the field is that biochemical signals alone are insufficient for full maturation. Endothelial cells require physical friction—shear stress—to form the tight junctions necessary for a functional vascular system. Furthermore, "faking" a low-oxygen environment (hypoxia) using stabilizers like DMOG can jumpstart natural angiogenic programs, prompting the organoid to actively recruit vasculature.
The use of the CAM model in chicken embryos has proven particularly valuable. It provides a high-throughput, accessible platform for real-time imaging, allowing researchers to observe how human cells integrate with a living circulatory system in a chimeric environment.
Results and Functional Outcomes
The integration of these technologies has led to significant improvements in organoid quality:
- Morphological Maturation: Organoids grown in dECM hydrogels exhibit significantly more mature nephron-like structures compared to those in synthetic gels.
- Enhanced Marker Expression: 3D bioprinted organoids show increased expression of vascular markers like CD31 and form functional connections with surrounding nephrons.
- Functional Filtration: In vivo transplantation in mouse models has successfully induced the expression of podocin and nephrin, indicating the formation of a primitive but functional filtration barrier mimicking native tissue.
Challenges and Future Prospects
Despite these advancements, several challenges remain. Lab-grown vascular networks are often fragile and prone to regression. Scaling these networks to support a full-sized, transplantable kidney remains a massive engineering task. Additionally, moving toward clinical applications introduces concerns regarding immune rejection and the long-term safety of genetically modified cells.
The future of the field lies in a synergistic approach—combining genetic engineering with advanced bioprinting and microfluidics—to transition from simple "vessel-like structures" to truly functional, perfusable organs.
Summary updated